Understanding the Role of Subcutaneous Opdivo Qvantig® (nivolumab and hyaluronidase-nvhy) Delivery in OncologyByKatie McKinney, PharmD, MS, Assistant Vice President – Pharmacy, St. Elizabeth HealthcareOctober 13th 2026This article was sponsored by Bristol Myers Squibb 1992-US-2600462 09/26